Investor directory
Novartis Venture Fund
The fund focuses on innovative life science companies that address unmet patient needs.
What they invest in
Sectors
Geographies
North AmericaEurope
The facts
- Typical cheque
- €5M – €10M
- Headquarters
- Basel, Switzerland
- Founded
- 1996
Portfolio
Rani Therapeutics (NAS: RANI)CitryllAverna TherapeuticsRedona TherapeuticsExositeTagworksAlesta TherapeuticsInflazomeCapstan TherapeuticsFlorida BiotechSoteria BiotherapeuticsArtiosBinxVivet TherapeuticsAerpioAnnexon Biosciences (NAS: ANNX)YourBio HealthAnokionAelin TherapeuticsGalera Therapeutics (OTCM: GRTXD)AkouosRibon TherapeuticsCatalymTScan Therapeutics (NAS: TCRX)
and 26 more
Does Novartis Venture Fund fit your round?
Oka scores this fund against your actual raise — stage, sector, cheque size and traction — and shows you who can introduce you.
Check your matchAre you Novartis Venture Fund? Tell us what to correct and we will update it — or ask us to remove the entry.